AIMD on Nasdaq
Ainos, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Virtuix Holdings Inc., INTERLINK ELECTRONICS INC or Wetouch Technology Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
82.9%Gross margin3
-11268.3%Operating margin3
-11897.0%Net margin3
499.0%Revenue growth, 20253
-195.3%Return on equity3
-$4.6MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue0¢$21.2K
- Research and development55¢$7.7M
- Selling, general and admin45¢$6.3M
- Income tax0¢$800
Out of $124.2K in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $124.2K | $20.7K |
| Cost of revenues | -$21.2K | -$52.6K |
| Gross profit (loss) | $102.9K | -$31.9K |
| Research and development expenses (including amounts for related party of $947,084 and $1,418,887 for the years ended December 31, 2025 and 2024, respectively) | $7.7M | $8.4M |
| Selling, general and administrative expenses | $6.3M | $5.4M |
| Total operating expenses | $14.1M | $13.8M |
| Loss from operations | -$14.0M | -$13.8M |
| Interest expense | -$711.9K | -$616.5K |
| Issuance cost of senior secured convertible note measured at fair value | -$308.3K | |
| Fair value change of senior secured convertible note | -$275.6K | |
| Other income (expenses), net | -$67.9K | $179.3K |
| Total non-operating expenses, net | -$779.8K | -$1.0M |
| Net loss before income taxes | -$14.8M | -$14.9M |
| Provision for income taxes | $800 | $800 |
| Net loss | -$14.8M | -$14.9M |
| Net loss per common share - basic | -$3.46 | -$7.82 |
| Net loss per common share - diluted | -$3.46 | -$7.82 |
| Weighted-average shares used in computing net loss per common share-basic | 4.3M shares | 1.9M shares |
| Weighted-average shares used in computing net loss per common share-diluted | 4.3M shares | 1.9M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $417.4K | $3.9M | |
| Accounts receivable | $22 | $56 | |
| Inventory, net | $295.6K | $143.8K | |
| Other current assets | $425.9K | $301.1K | |
| Total current assets | $1.1M | $4.3M | |
| Intangible assets, net | $19.2M | $23.7M | |
| Property and equipment, net | $343.3K | $559.6K | |
| Other assets | $163.0K | $174.4K | |
| Total assets | $20.9M | $28.8M | |
| Accrued expenses and other current liabilities | $728.7K | $848.6K | |
| Total current liabilities | $1.1M | $4.0M | |
| Convertible notes payable - noncurrent (including amounts to related party of $11,000,000 and $9,000,000 as of December 31, 2025 and 2024, respectively) | $11.0M | $9.0M | |
| Other long-term liabilities | $1.2M | $348.9K | |
| Total liabilities | $13.3M | $13.3M | |
| Common stock, $0.01 par value; 300,000,000 shares authorized as of December 31, 2025 and 2024; 6,982,675 shares and 3,085,477 shares issued and 5,882,675 and 3,085,477 shares outstanding as of December 31, 2025 and 2024, respectively | $69.8K | $30.9K | |
| Treasury stock, at cost (1,160,000 and nil shares held as of December 31, 2025 and 2024, respectively) | -$2.0M | ||
| Additional paid-in capital | $77.2M | $68.6M | |
| Accumulated deficit | -$67.5M | -$52.7M | |
| Accumulated other comprehensive loss - translation adjustment | -$249.3K | -$409.5K | |
| Total stockholders equity | $7.6M | $15.5M | $24.4M |
| Total liabilities and stockholders equity | $20.9M | $28.8M | |
| Contract liabilities current | $350.0K | $106.3K | |
| Convertible notes payable current | $3.0M | ||
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, shares authorized | 50.0M shares | 50.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 7.0M shares | 3.1M shares | |
| Common stock, shares outstanding | 5.9M shares | 3.1M shares | |
| Stock issued in exchange for subsidiary shares | 1.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$14.8M | -$14.9M |
| Depreciation and amortization | $4.8M | $4.8M |
| Share-based compensation expense | $1.7M | $3.5M |
| Stock issued for special stock bonus | $2.7M | $89.0K |
| Issuance cost of senior secured convertible note measured at fair value | $308.3K | |
| Issuance of common stock for consulting services | $225.0K | |
| Changes in fair value of senior secured convertible note | $275.6K | |
| Gain on disposal of property, plant and equipment | -$1.1K | |
| Accounts receivable | $34 | $399 |
| Inventory | -$151.8K | $23.8K |
| Other current assets | -$123.1K | $118.4K |
| Accrued expenses and other current and long-term liabilities | $1.0M | -$105.6K |
| Net cash used in operating activities | -$4.6M | -$5.8M |
| Purchase of property and equipment | -$34.6K | -$21.3K |
| Decrease (Increase) in refundable deposits and other assets | $32.3K | -$104.0K |
| Net cash used in investing activities | -$2.2K | -$125.3K |
| Proceeds from convertible notes payable- noncurrent, related party | $9.0M | |
| Proceeds from senior secured convertible notes payable | $875.0K | |
| Proceeds from at-the-market offering, net of issuance costs | $2.0M | |
| Repayment of convertible notes payable | -$1.0M | |
| Repayment of senior secured convertible notes payable | -$1.4M | |
| Repayment of other notes payable, related party | -$312.0K | |
| Payment of issuance cost of senior secured convertible note measured at fair value | -$97.5K | |
| Fractional shares paid out in cash for the reverse stock split | -$260 | |
| Net cash provided by financing activities | $1.0M | $8.0M |
| Effect from foreign currency exchange | $132.9K | -$84.9K |
| Net (decrease) increase in cash and cash equivalents | -$3.5M | $2.0M |
| Cash paid for interest | $32 | $21.7K |
| Cash paid for income taxes | $800 | $800 |
| Issuance of common stock for consulting services | $225.0K | |
| Conversion of senior secured convertible notes to common stock | $2.4M | |
| Receivable from disposal of property, plant and equipment | $1.7K | |
| Issuance of common stock for exchanging subsidiary company shares | $2.0M |
Former names
- AMARILLO BIOSCIENCES INCMay 30, 1996 to Mar 30, 20212
Recent filings
- Sep 28, 20268-K
- Aug 3, 202610-Q
- Aug 3, 20268-K
- Jul 24, 2026424B5
- Jul 10, 20268-K
- Jul 9, 20268-K
- Jun 9, 20264
- Jun 5, 20264
- Jun 1, 20264
- May 29, 20264
- May 27, 20264
- May 27, 20264
- May 27, 20264
- May 26, 20264
- May 20, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAinos, Inc. filings on SEC EDGAR
- 2SEC EDGARAinos, Inc. filings on SEC EDGAR
- 3SEC EDGARAinos, Inc. 10-K for fiscal 2025
- 4SEC EDGARAinos, Inc. 10-K for fiscal 2019
- 5SEC EDGARAinos, Inc. 10-K for fiscal 2020
- 6SEC EDGARAinos, Inc. 10-K for fiscal 2021
- 7SEC EDGARAinos, Inc. 10-K for fiscal 2022
- 8SEC EDGARAinos, Inc. 10-K for fiscal 2023
- 9SEC EDGARAinos, Inc. 10-Q for fiscal 2026
- 10SEC EDGARAinos, Inc. 10-Q for fiscal 2026